Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06031090
Other study ID # zu-IRB#10415/26-2-2023
Secondary ID
Status Recruiting
Phase Phase 2
First received
Last updated
Start date March 5, 2023
Est. completion date October 30, 2023

Study information

Verified date September 2023
Source Zagazig University
Contact Heba M Fathi, M.D
Phone 00201000143938
Email heba_elgendi@yahoo.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Prevention of post spinal anesthesia shivering during cesarean section with its associated discomfort, distress, aggravation of pain, increased metabolic demands, and increased oxygen consumption


Description:

Shivering is one of the most important periperative complications seen in clinical practice. Several mechanisms have been postulated for its pathogenesis. Anesthetic-induced inhibition of thermoregulation resulting in hypothermia is an important cause of post anesthesia shivering, uncontrolled spinal reflexes, and cutaneous vasodilation are the other suggested mechanisms involved in the pathogenesis of shivering. Opioid receptors, α2 receptors, and serotonergic receptors also are involved of shivering. Various drugs were studied for their potential role in prevention of peri-operative shivering such as tramadol, dexmedetomidine, ondansetron, ketamine, and pethidine. We decided to perform a well-designed study to compare clonidine and granisetron which has been recently introduced as drugs for prevention and control of shivering after spinal anesthesia.


Recruitment information / eligibility

Status Recruiting
Enrollment 186
Est. completion date October 30, 2023
Est. primary completion date October 5, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 21 Years to 40 Years
Eligibility Inclusion Criteria: Patient acceptance.,Aged between 21-40 years old, BMI: 18- 30 kg/m2, ASA: I and II., Scheduled for elective cesarean section under spinal anesthesia. - Exclusion Criteria: History of hypersensitivity to drugs used in this study,Patients with history of chronic pain and taking analgesics, Patients with sepsis and Significant cardiac, liver or renal diseases, Uncooperative patients or with psychiatric disorders that prevent surgery under spinal anesthesia, Atrio-ventricular block in any degree, cardiac arrhythmias, valvular heart disease, kidney or liver diseases, neuromuscular disorders and diabetes mellitus -

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Clonidine Injection
intravenous Clonidine 0.5 µg/kg diluted in 10ml normal saline 20 minutes before spinal anesthesia
Granisetron Injection
intravenous 1mg of granisetron diluted in 10ml normal saline 20 minutes before spinal anesthesia.
Normal Saline 10 mL Injection
intravenous 10 ml normal saline 20 minutes before spinal anesthesia

Locations

Country Name City State
Egypt Heba M Fathi Zagazig

Sponsors (1)

Lead Sponsor Collaborator
Zagazig University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Other maternal oxygen saturation Procedure (preoperative as base and through out the period of spinal anesthesia)
Primary Incidence of Shivering • Shivering will be graded according to Tsai and Chu scale (10): 0 = no shivering, 1 = piloerection or peripheral vasoconstriction but no visible shivering, 2 = muscular activity in only one muscle group, 3 = muscular activity in more than one muscle group but not generalized shivering, 4 =shivering involving the whole body Procedure (through out the period of spinal anesthesia)
Secondary core body temperature Core body temperature was detected by measuring tympanic membrane temperature using digital infrared ear thermometer (thermoscan KFT-10; Grnzia, genova, Italy). Procedure (preoperative as base and through out the period of spinal anesthesia)
Secondary Maternal Heart rate beats/minute Procedure (preoperative as base and through out the period of spinal anesthesia)
Secondary baby APGAR score 1 minutes and 5 minutes post natal
Secondary maternal blood presure mmhg Procedure (preoperative as base and through out the period of spinal anesthesia)
See also
  Status Clinical Trial Phase
Completed NCT04266145 - Intravenous Versus Perineural Dexmedetomidine as Adjuvant in Adductor Canal Block for Total Knee Arthroplasty N/A